Teva Pharmaceutical Industries Limited’s TEVA share price has dipped by 10.66%, which has investors questioning if this is ...

TEL AVIV, Israel, March 27, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q1 2025 Aide Memoire is available on the “Investors ...

"When we gave the forecast, there were people who were a little disappointed," Francis said at the company's annual meeting ...

If approved for an expanded pediatric indication, AJOVY would be the first calcitonin gene-related peptide (CGRP) antagonist ...

TEL AVIV (Reuters) - Allergan (N:AGN) will make a one-time payment of $700 million to Teva Pharmaceutical Industries (TA:TEVA) to ...

The main indices on the Tel Aviv Stock exchange feel sharply at the opening of trading this morning, following the steep ...

N.J. and TEL AVIV, Israel, March 31, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), today announced the presentation of a patient ...

Bank Leumi (TASE: LUMI) led the market today, rising 2.18% on the day's biggest trading turnover. Bank Hapoalim (TASE: POLI) rose 1.32%, Israel Discount Bank (TASE: DSCT) rose 2.17% and Mizrahi ...

Following the release, Teva will conduct a conference call and live webcast on the same day, at 8:00 a.m. ET. In order to participate, please register in advance here to obtain a local or toll-free ...

TEL AVIV, Israel, March 27, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q1 2025 Aide Memoire is available on the “Investors” page on its ...

If approved for an expanded pediatric indication, AJOVY would be the first calcitonin gene-related peptide (CGRP) antagonist for migraine prevention in adults and episodic migraine prevention in ...